Development of a cancer vaccine strategy by tumor antigen targeting to CD169+ antigen presenting cells.
- den Haan, J. (Speaker)
Activity: Talk or presentation › Oral presentation › Academic
Activity: Talk or presentation › Oral presentation › Academic